Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure on replacement therapy

19 May 2025 (15:36 - 15:45)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Jong-Chan Youn

Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul (Korea (Republic of))

4 More presentations in this session

Presentation thumbnail

Discrepancy in supine versus upright exercise hemodynamic testing and the impact on the diagnostic performance of H2FPEF and HFA-PEFF scores in patients with unexplained dyspnea

Doctor V. kittipibul (Durham, US)

Abstract Slides Video

Presentation thumbnail

Residual inflammation after myocardial infarction detected by somatostatin receptor PET predicts long-term adverse cardiac remodelling: findings of a parallel-design longitudinal cohort study

Doctor A. Corovic (Cambridge, GB)

Abstract Slides Video

Presentation thumbnail

Cardiac resynchronization therapy: an enabler for GDMT optimization in HFrEF? Data from the Swedish Heart Failure and the Swedish Pacemaker and Implantable Cardioverter-Defibrillator Registries.

Doctor D. Tomasoni (Brescia, IT)

Abstract Slides Video

Presentation thumbnail

Mitral regurgitation in patients with heart failure and reduced ejection fraction and clinical outcomes: Insights from GALACTIC-HF

Doctor M. Chimura (Glasgow, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Advancing heart failure diagnosis and management: insights from hemodynamics, inflammation, and emerging therapies

The Event

Event poster

Heart Failure 2025

19 May 2025 15:36 CET

You may be interested in

Congress Presentation

Real-world comparison between ARNI and RAS Blockade in Patients with HFrEF

Congress Session

Pharmacotherapy

Congress Session

Treating heart failure with diabetes and renal disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources